vaccigrade cyclic di amp (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
94
Structured Review
InvivoGen
vaccigrade cyclic di amp
Vaccigrade Cyclic Di Amp, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclic+di+amp/c-di-AMP+VacciGrade/us12290603-475-11-13
Average 94 stars, based on 8 article reviews
Vaccigrade Cyclic Di Amp, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclic+di+amp/c-di-AMP+VacciGrade/us12290603-475-11-13
Average 94 stars, based on 8 article reviews
vaccigrade cyclic di amp - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Infection:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Cell Culture:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Sampling:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Molecular Weight:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Staining:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Isothermal Titration Calorimetry:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Binding Assay:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Modification:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Formulation:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Comparison:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Adjuvant:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Mutagenesis:Article Title: Enabling Sublingual Peptide Immunization with Molecular Self-assemblies Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of Article Title: A sublingual nanofiber vaccine to prevent urinary tract infections Article Snippet: Adjuvants were included in formulations at the following dosages per mouse: 10 μg of CTB subunit (List Labs, 104), 10 μg of cyclic di-AMP (InvivoGen, vac-nacda), 25 μg of Article Title: Enabling sublingual peptide immunization with molecular self-assemblies. Article Snippet: Adjuvanted formulations included 2 μg of cholera toxin (List Biological Laboratories, 101B), 10 μg of CTB (List Biological Laboratories, 103B), or 10 μg of |